参考文献/References:
[1] Chahine LM,Amara AW,Videnovic A.A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015[J].Sleep Med Rev,2016,8(1):1-18.
[2] Stavitsky K,Cronin-Golomb A.Sleep quality in Parkinson disease:an examination of clinical variables[J].Cogn Behav Neurol,2011,24(2):43-49.
[3] Poryazova R,Benninger D,Waldvogel D,et al.Excessive daytime sleepiness in Parkinson's disease:characteristics and determinants[J].Eur Neurol,2010,63(3):129-135.
[4] Arnulf I,Konofal F,Merino-Andreu M,et al.Parkinson's disease and sleepiness_an integral part of PD[J].Neurology,2002,58(7):1019-1024.
[5] Pavese N.Imaging the aetiology of sleep disorders in dementia and Parkinson's disease[J].Curr Neurol Neurosci Rep,2014,14(12):501.
[6] Compta Y,Santamaria J,Ratti L,et al.Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia[J].Brain,2009,132(12):3308-3317.
[7] Braak H,Del Tredici K,Rüb U,et al.Staging of brain pathology related to sporadic Parkinson's disease[J].Neurobiol Aging,2002,24(2):197-211.
[8] Gama RL,Tavora DG,Bomfim RC,et al.Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy-a comparative study[J].Parkinsonism Relat Disord,2010,16(4):275-279.
[9] Videnovic A,Noble C,Reid KJ,et al.Circadian melatonin rhythm and excessive daytime sleepiness in parkinson disease[J].JAMA Neurol,2014,71(4):463-469.
[10] Ael AR,Shapiro CM.Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older(ergot)vs newer(nonergot)dopamine agonists[J].Arch Neurol,2004,61(1):97-102.
[11] Gjerstad MD,Alves G,Wentzel-Larsen T,et al.Excessive daytime sleepiness in Parkinson disease:is it the drugs or the disease?[J].Neurology,2006,67(5):853-858.
[12] Keisuke SM,Miyamoto T,Hirata K.Parkinson's disease and SleepWake disturbances[J].Current Neurology&Neuroscience Reports,2015,15(3):8.
[13] Hobson DL,Martin WR.Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease_a survey by the Canadian Movement Disorders Group[J].JAMA Neurol,2002,287(6):455-463.
[14] Videnovic A,Golombek D.Circadian and sleep disorders in Parkinson's disease[J].Exp Neurol,2013,243(SI):45-56.
[15] Olanow CS,Sethi K.The scientific and clinical basis for the treatment of Parkinson disease[J].Neurology,2009,72(21 Suppl 4):S1-S136.
[16] Videnovic A,Klerman EB,Wang W,et al.Timed light therapy for sleep and daytime sleepiness associated with parkinson disease:a randomized clinical trial[J].JAMA Neurol,2017,74(4):411-418.
[17] Zesiewicz TH.Sleep attacks and dopamine agonists for Parkinson's disease_what is currently known?[J].CNS Drugs,2003,17(8):593-600.
[18] Paus S,Brecht HM,Koster J,et al.Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease[J].Movement Disorders,2003,18(6):659-667.
[19] Valko P,Waldvogel D,Weller M,et al.Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms,depression and dopaminergic treatment[J].Eur J Neurol,2010,17(12):1428-1436.
[20] Diederich NJ,Mcintyre DJ.Sleep disorders in Parkinson's disease: Many causes, few therapeutic options[J].J Neurol Sci,2012,314(1/2):12-19.
[21] Loddo G,Calandra-Buonaura G,Sambati L,et al.The treatment of sleep disorders in parkinson's disease:from research to clinical practice[J].Front Neurol,2017,8(1):42.
[22] Zesiewicz TA,Sullivan KL,Arnulf I,et al.Practice parameter: treatment of nonmotor symptoms of parkinson disease: report of the quality standards subcommittee of the American academy of neurology[J].Neurology,2010,74(11):924-931.
[23] Stahl SM.Awakening to the psychopharmacology of sleep and arousal: Novel neurotransmitters and wake-promoting drugs[J].Journal of Clinical Psychiatry,2002,63(6):467-468.
[24] Rodrigues TM,Caldas AC,Ferreira JJ.Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease.: Systematic review and meta-analysis[J].Parkinsonism Relat Disord,2016,27(1):25-34.
[25] Seppi K,Weintraub D,Coelho M,et al.The movement disorder society Evidence-Based medicine review update: treatments for the non-motor symptoms of parkinson's disease[J].Mov Disord,2011,26(Suppl 3):S42-S80.
[26] Ondo WP,Swick T.Sodium oxybate for excessive daytime sleepiness in Parkinson disease an open-label polysomnographic study[J].Arch Neurol,2008,65(1):1337-1340.
[27] Devos D,Krystkowiak P,Clement F,et al.Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease[J].J Neurol Neurosurg Psychiatry,2007,78(5):470-475.
[28] Postuma R.Caffeine for treatment of Parkinson disease: A randomized controlled trial(vol 79, pg 651, 2012)[J].Neurology,2012,79(16):1744.
[29] Palacios N,Gao X,Mccullough ML,et al.Caffeine and risk of Parkinson's disease in a large cohort of men and women[J].Movement Disorders,2012,27(10):1276-1282.
[30] Dowling GA,Mastick J,Colling E,et al.Melatonin for sleep disturbances in Parkinson's disease[J].Sleep Med,2005,6(5):459-466.
[31] Qin ZH,Zhang LY,Sun F,et al.Health related quality of Life in early Parkinson's disease: Impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort[J].Parkinsonism Relat Disord,2009,15(10):767-771.
[32] Meindorfner C,Korner Y,Moller JC,et al.Driving in parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel[J].Movement Disorders,2005,20(7):832-842.